App-Quantinova.ai

Chronic Overexpression of Heat Shock Protein 27 Facilitates Favorable Plaque Remodeling?

Dominique Tremblay - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arterial stiffness

Nitroprusside sodium

Impact of a Single Mixed Mediterranean-Type Meal Compared with a High-Saturated Fat Meal on Postprandial Endothelial Function and Metabolic Markers

Christine Des Rosiers - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Vasodilation dysfunction

N/A

Soluble CD40 Ligand Stimulates the Pro-angiogenic Function of Early Endothelial Progenitor Cells by Increasing Matrix Metalloproteinase 9 Release via the p38 Mitogen-Activated Protein Kinase Pathway

Ahmed Hachem - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

N/A

Sapropterin

Extracellular Heat Shock Protein 27 Signals Through NF-?B to Favorably Modulate Macrophage Inflammation

Chunhua Shi - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Atherosclerotic lesions

BAY117082

Extracellular Heat Shock Protein 27 Inhibits Foam Cell Formation by Targeting Scavenger Receptor-A in the Vessel Wall

Yong-Xiang Chen - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Serpin Suppression of Macrophage and T Helper Cell Response in Temporal Artery Biopsy Xenograft Implants from Patients with Giant Cell Inflammatory Arteritis

Donghang Zheng - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

Glucocorticoid

The RNA-binding Protein Quaking Critically Regulates Vascular Smooth Muscle Cell Phenotype

Ruben G de Bruin - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Angiology

Calcified vascular disease

N/A

The Historical Stroke Severity Score Predicts Stroke Progression in TIA and Minor Stroke

Andrew M Demchuk - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Recanalization of Proximal Arterial Occlusion in the SENTIS Trial

Ashfaq Shuaib - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Pre-existing Dementia, Death And Disability After Ischemic Stroke: Results From A Propensity-score Matched Analysis

Moira Kapral - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

N/A

Benefits Of Clinical Trial Participation For Risk Factor Control: Experience From The SPS3 Study

Carole White - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Validity of the NINDS-CSN VCI Neuropsychological Protocols is Supported in a Sample of Ischemic Stroke Patients

Anoop Ganda - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Dipyridamole Induced Headache Indicates Lower Recurrence Risk in Secondary Prevention of Ischemic Stroke

Ralph Sacco - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

dipyridamole

Favorable Vascular Profile Is An Independent Predictor Of Outcome: A Post Hoc Analysis Of The Sentis Trial

Martin Kohrmann - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

N/A

Blood Brain Barrier Permeability Increases in Intracerebral Hemorrhage do not Predict Perihematoma Edema Growth

Rebecca McCourt - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

N/A

Autoregulation of Cerebral Blood Flow is Preserved in Primary Intracerebral Hemorrhage

Rebecca McCourt - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

N/A

Validity and Reliability of Retrospective Scoring of the Pediatric NIH Stroke Scale

Scott E. Kasner - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

Aloxistatin

The Comparative Importance of Share- Risk Factors for Ischemic Stroke and Intracerebral Hemorrhage in Patients with Atrial Fibrillation

Emer R McGrath - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

Prevalence and Characterization of Cerebral Microbleeds in Lacunar Stroke Patients: Observations from the Secondary Prevention Small Subcortical Strokes (SPS3) Trial

Jeff Szychowski - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

White matter hyperintensities

N/A

DWI Reversal is associated with Small Infarct Volume and Early Reperfusion in Patients with TIA and Minor Stroke. Data from VISION and CATCH study groups

Jonathan I Coulter - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Filters

28841 Abstracts